Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Topia Stress-Free is a pharmaceutical product developed by the 960th Hospital of the PLA (formerly the Zibo Hospital) specifically for the treatment of depression. While the name "Topia" is often associated with topiramate in certain clinical contexts in China, Topia Stress-Free is positioned as a specialized antidepressant formulation or product within the hospital's psychiatric practice. The 960th Hospital, known for its expertise in mental health and psychiatry, developed this agent to address symptoms of depression and stress-related disorders. The exact chemical composition is often discussed in the context of the hospital's proprietary clinical applications, but it is primarily indicated for patients suffering from various forms of depressive illness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Topia Stress-Free.